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Introduction: This paper investigates levels of depressive symptoms among older children and young adolescents, 11–14 
years of age. The population-based sample was assessed twice during a 12-month period. Point-prevalence, 12-month 
prevalence, and 12-month incidence were measured by a validated self-reported scale (SFMQ) and are presented in this paper.  
Methods: A total of 2148 pupils were invited to participate in this study, and 1748 pupils and at least one parent/guardian 
provided informed consent. The population was assessed twice within one 12-month period resulting in 1439 participants at 
both data collection points.  Depressive symptoms were measured by a validated self-reported scale, The Short Mood and 
Feelings Questionnaire (SMFQ).  
Results: The results indicate that the point-prevalence was just under 10% in 6th to 10th grade with a 12-month prevalence at 
almost 3%. The results also indicate an incidence rate of 4.5% over 12-months. This study confirms that girls report a higher 
range of point prevalence, 12- month-prevalence, and 12-month incidence compared to boys.  
Conclusions: The results indicate that depressive symptoms among children and young adolescents is a serious health 
challenge. The results demonstrate substantial gender differences even at an early age (11-14 years), where girls report 
significantly higher point prevalence, 12-month-prevalence, and 12-month incidence compared to boys. Results from this 
study suggest that depressive symptoms are an important problem that young adolescents face, and the study underlines the 
need for more intervention tailored to gender at the middle-school level, especially with respect to those children and 
adolescents who experience persistent depressive symptoms. 
 




Depression in the population is a public health 
concern due to high prevalence rates, early onset and 
its impact on children and adolescents, families, and 
communities (1, 2). Depression in adulthood is a 
debilitating mental illness with clear developmental 
patterns from childhood through adolescence (3). 
Moreover, depression in childhood increases the risk 
of future episodes during adolescence (4, 5), and it 
adversely affects quality of life, motivation and 
learning (6-8). Depression among adults is associated 
with problems regarding interpersonal relationships 
(4), substance misuse (9), self-harm and suicide (10). 
Furthermore, major depressive disorder among 
youth has the greatest impact of any disorder, with 
more than 40% of young people experiencing a 
severe negative impact on their life (11).  
Common symptoms of depression in adults are 
decreased energy, loss of motivation and initiative, 
increased degree of irritation, impaired concentration 
and memory, poorer self-esteem, guilt, shame and 
worthlessness, poor night's sleep, weight gain or 
weight loss, and suicidal thoughts and actions (12). 
Equal diagnostic criteria are employed to define 
major depressive disorder in children/adolescents 
and adults. The one exception to this is that DSM-IV 
and 5 (12, 13) allow for irritable rather than 
depressed mood as a core diagnostic mood symptom 
for children/adolescents. In systematically 
comparing adolescent and adult major depression 
symptoms profiles, Rice et al. (2019) demonstrated 
that appetite, weight change, energy loss and 
insomnia were more common in adolescents, while 
loss of interest, anhedonia and concentration 





problems were more common in adults. Further, the 
results were similar for depressive symptom count 
and major depressive disorder (14).  
The diagnostic criteria for depressive disorders are 
the same for children and adults, but children’s 
depression will be characterised by their cognitive 
development and developmental age. Among young 
children, emotional disturbances, aggression, 
passivity, anxiety, behavioural difficulties, instability 
and restlessness, hyperactivity, isolation and various 
physical disorders, such as abdominal pain, can be 
symptoms of depression. Among depressed 3-6-
year-olds, it was found that the depression was 
strongly characterised by guilt and extreme fatigue 
(15).  
A comorbid relationship has been found between 
depressive disorders among older children/ young 
adolescents and bulimia nervosa (16), anxiety and 
behavioural disorders (17), neuropsychiatric 
disorders such as ADHD (18), obsessive-compulsive 
disorder (19) and language disorders  (20).  
 
Prevalence 
The prevalence of depression has been reported to 
be rather low, 0.08 % among children 3-5 years of 
age and 1.7 % between the ages 6–11 (21). An 
increase in the prevalence rate has been 
demonstrated in the transition period from 
childhood to adolescence; for example, the 
prevalence among adolescents between ages 12–17 is 
reportedly 6.1 %  and 7.7% (11). A meta-analysis 
including 26 studies indicated a lower prevalence 
among children compared to adolescents: 2.8% for 
those under age 13 and 5.6% between the ages of 13–
18 (22). Reported prevalence of depression and 
depressive symptoms in adolescents varies across 
studies. Wartberg and colleagues reported an 
estimated point prevalence of depressive symptoms 
at 8.2% among adolescents 12 to 17 years of age (23), 
compared to Saluja and colleagues, who reported that 
nearly 20% of young adolescents in grades 6, 8, and 
10 in the US report symptoms consistent with 
depression (24). 
Many children and adolescents struggle with 
depression or anxiety throughout adolescence. 
However, only a small percentage of these children 
will have such severe symptoms that require 
treatment (25).  
 
Incidence 
The incidence of depression is reported as 
significantly lower than point-prevalence. Garrison et 
al. noted a 12-month incidence of 3.3% for major 
depression in adolescents aged 11–16 years of age, 
based on structured interviews about symptoms and 
impairment and having identified dates of onset and 
duration.  In addition, Lewinsohn et al. recorded an 
annual first incidence rate of 5.7% for major 
depressive disorder among high school students.   
 
Gender differences 
Before puberty, boys and girls appear to have similar 
rates of depression (22, 28). However, gender 
differences have been reported to emerge between 
the ages of 13 and 15 years, and the point prevalence 
of depression after puberty is preponderant in girls 
(about 2:1) (29, 30). Gender differences in a 12-
month prevalence was found among older 
adolescents in a study of adolescents 15–19 years of 
age. For DSM-III-R major depressive episode, 
Haarasiltaet al. reported a 12-month prevalence of 
6.0% among girls and 4.4% among boys, and 
observed in their study that 17.3% of girls between 
12 to 17 years of age met the criteria for 12-month 




Most studies investigate the occurrence of depressive 
symptoms among teenagers (23, 33, 34). In contrast, 
there is a lack of population-based studies examining 
depressive symptoms among the younger age groups. 
Furthermore, most studies report results based on 
only one assessment. A point-prevalence often 
provides merely a “snapshot” of how adolescents 
perceive their mood. Adolescence is a period 
characterised by transitions and shifting relationships 
and emotions (35-37) and have demonstrated that 
adolescents often report transitory depressive 
symptoms. Thus, to explore and evaluate the 
difference between point-prevalence and time-point 
prevalence, a study is warranted to examine the same 
sample repeatedly. Moreover, to our knowledge, no 
study has examined point prevalence, 12-month 
prevalence, and 12-month incidence among a 
representative sample of adolescents aged 11 to 14.  
The aim of this study is to assess potential gender 
differences in point prevalence, 12-month 
prevalence, and 12-month incidence rates among 
children in 6th to 10th grade (age 11–14 years) by 
administering an established and robust self-report 
questionnaire twice within a twelve-month interval. 
 
Method 
Participants and procedure  
All pupils in 6th –10th grade from 27 schools in two 
municipalities were invited to participate in the study. 
These two municipalities function as a representative 
sample of Norway in terms of geography, industry, 
income level, age distribution, morbidity and 
mortality, thereby making them appropriate for an 
epidemiological investigation (38).  
A total of 2148 pupils were invited to participate in 
this study, and 1748 pupils and at least one 





parent/guardian provided informed consent. The 
population was assessed twice within one 12-month 
period resulting in 1439 participants at both data 
collection points. The data collection was carried out 
as part of the project "Health and Well-being", which 
specifically examined the prevalence and effect of a 
universal preventive programme aimed at reducing 
social anxiety (39).  
Teachers responsible for each class were given 
instructions on how to distribute consent forms and 
conduct the assessments. Written information about 
the study “Health and well-being” and consent forms 
were distributed to pupils by a teacher during a class 
session and were taken home to parents/guardians. 
The questionnaire forms were handed out by a 
teacher in the classroom and completed in the 
presence of the teacher. Almost all pupils completed 
the questionnaires in one session and within the 45-
minute period allocated. In addition to the SMFQ, 
the booklet also included various scales assessing 
anxiety, stressful life events, resilience and quality of 
life. The schools in Norway are highly integrated 
containing severe intellectually and physically 
handicapped children and adolescents. Six pupils 
with severe mental retardation and extensive reading 
comprehension difficulties were excluded from the 
study.   
 
Measurement 
A self-reporting questionnaire was used in this 
population study. Depressive symptoms were 
measured by The Short Mood and Feelings 
Questionnaire (SMFQ) (40, 41). SMFQ is a 13-item 
self-report questionnaire designed to measure core 
depressive symptomatology in children and 
adolescents aged 6–17 years old. SMFQ assesses 
symptoms of depression during the past 2 weeks. All 
13 items are negatively phrased and rated on a 3-
point Likert scale with response categories ranging 
from 0 (Not true) to 2 (True). Example items include 
“I felt miserable or unhappy”, “I did everything 
wrong” and “I cried a lot”. Total scores range from 
0 to 26, and high sum scores indicate high levels of 
depression symptomatology. SMFQ has been found 
to differentiate between depressed adolescents and 
non-depressed adolescents in the general population 
(42, 43), and there is good evidence of SMFQ’s 
psychometric properties such as conceptual validity, 
convergent validity and reliability (44). The SMFQ is 
a unifactorial measure with a high reliability score of 
α = 0.90 in Cronbach’s alpha (45). Cronbach’s alphas 
for the 13 depression items in this study was (α = 
0.88) at assessment point 1 and (α = 0.86) at 
assessment point 2.  
In a large population-based study that surveyed 
10,220 adolescents 16–18 years of age, assessing both 
sleep and depression, the 90th percentile has been 
used as a cut-off score for SMFQ (46). A 90th 
percentile in our population is a total score of 10 for 
SMFQ at assessment point 1. We used a total score 
of 11 or higher for SMFQ to classify high levels of 
depressive symptoms and avoid over-reporting.  
 
Ethical consideration 
The Regional Committee for Medical and Health 
Research Ethics approved the re-use of data to 
investigate depressive symptoms among children and 
adolescents (REK) 2015/2315. Written information 
about this new project was sent by regular mail to the 
participants in the “Health and well-being” survey. 
The informants were given the opportunity to 
decline data reuse. One participant gave written 
feedback expressing that they did not want to attend 
the new study. All data obtained regarding this 
written information was deleted.  
Data is stored anonymously and separately from 
identifiable name lists. Consent declarations and 
name lists are kept secure and locked away in line 
with recommendations from the Regional 
Committee for Medical and Health Research Ethics. 
 
Statistics 
Statistical analyses were conducted using the SPSS, 
Version 23.0 software (47). We present the specific 
point prevalence rates assessed across gender at both 
assessment points, the 12-month prevalence and 12-
month incidence rates. In keeping with previous 
research, we defined depression cases at 12 months 
as having an SMFQ score of 11 or greater at each 
assessment point (48). Moreover, the 12-month 
incidence rates include those who scored above ≥ 11 
at the second but not the first assessment point. Chi-
squared analyses were used to investigate potential 
gender differences in point prevalence, 12-month 
prevalence and 12-month incidence. Effect sizes are 
defined as follows: Cramer’s V (49), no effect (0–
0.099), low (0.100–0.299), moderate (0.300–0.499) 
and strong effect (≥ 0.5) (50). The significance level 
is set at 5% (51). 
 
Results 
A total of 2,148 pupils were invited to the study.  A 
total of 1748 (81.6%) children and adolescents aged 
11-14, 892 girls (51%) and 856 boys (49%), 
participated at assessment point. Further, 1439 
participated at both assessment points. The average 
age of those who participated at both assessment 
points was 12.6 year (SD=1.09). 
 
Point prevalence 
The point prevalence among adolescents aged 11-14 
was 9.3% at the first assessment point and 7.9% at 
the second assessment point. An independent chi-
squared analysis confirmed a significant reduction in 











point prevalence differences between assessment 
point 1 (9.3%) and assessment point 2 (7.9%),  χ² (1) 
= 117.180 p < .000. At the first assessment point, 
12.2 % of the girls and 6.1 % of the boys reported a 
high level of depressive symptoms (SMFQ ≥ 11). An 
independent chi-squared analysis indicated 
significant gender differences in point prevalence at 
the first assessment point, χ² (1) = 15.993 p < .001, 
Cramer`s V = .106. At the second assessment point, 
10.8% of girls and 4.8% of the boys reported high 
levels of depressive symptoms (SMFQ ≥ 11), and an 
independent chi-squared analysis revealed significant 
gender differences χ² (1) = 17.509 p < .001, Cramer`s 
V = .110. 
 
12-month prevalence  
The 12-month prevalence among the population was 
2.9 %, and an independent chi-squared analysis also 
indicated significant gender differences in 12-month 
prevalence, 4.5 % for girls and 1.3 % for boys, χ² (1) 
= 12.307 p < .05, Cramer’s V= .093.  
 
12-month incidence 
The 12-month incidence is 4.8% in the population, 
and an independent chi-squared analysis indicated 
significant gender differences in 12-month incidence, 
6.1 % for girls and 3.5 % for boys, χ² (1) = 7.518 p < 
.05, Cramer’s V= .073.  
 
Discussion 
The results from this study show that almost 10 % of 
pupils in 6th to 10th grade report high levels of 
depressive symptoms. In contrast, only 3% report a 
12-month prevalence. Moreover, nearly 5% of the 
sample report a 12-month incidence. Our results 
demonstrate that girls are twice as likely as boys to 
experience a high range of point prevalence and 12-
month incidence. Further, girls are three times as 




Point prevalence is the proportion of a population 
with a disease or particular condition at a specific 
point in time (52). The point prevalence across the 
entire sample was 9.3% at the first assessment point 
and 7.9% at the second assessment point. At both 
assessment points, girls (12.2 % and 10.8%) report a 
point prevalence twice as high compared to boys 
(6.1% and 4.8%). These results demonstrate a gender 
difference in point prevalence even at an early age 
(11-14 years). Gender differences have also 
previously been reported among older adolescents 
(53, 54), whereas Bakken and colleagues (2017), 
assessing an older sample of adolescents (13-19 years 
old), reported a point prevalence of 29.3% and 
10.8 %  for female and males, respectively. 
The discrepancies in point prevalence across 
reported studies may be dependent on several 
factors. The SMFQ has been employed in a variety 
of studies, and discrepancies in prevalence is 
reported depending on the cut-off score utilised for 
SMFQ. Recommended clinical cut‐offs vary between 
≥4 (55), ≥6 (56), ≥8 (42, 57, 58), ≥10 (59), ≥11 (40, 
48) and ≥12 (60). The SMFQ should not be used to 
make a definitive diagnosis of depression. It has 
usefulness as a screening tool for situations where 
depression is suspected, and as an aid toward 
following a child’s symptom severity and treatment 
response over time. Employing a cut off score of 8 
or higher  is considered significant, and has revealed 
a 60% sensitivity and 85% specificity for the SMFQ 
(42). 
In accordance with previous research, and to 
reduce type II error, we defined “depression” by 
employing a stringent SMFQ score of 11 or greater 
(48). 
Further, the discrepancies in prevalence may also 
be due to differences in means of assessment. For 
instance, in our study we ask about the presence of 
depressive symptoms over the past two weeks using 
a validated self-report questionnaire specifically 
TABLE 1. Point prevalence, 12-month prevalence and 12-month incidence among the total population, and separately among girls and 
boys at age 11-14 years 
 Total Girls 746 (51.9%) Boys 691 (48.1 %) 
Total N % CI n % CI n % CI 
Point prev. 1 133 9.3  7.80 - 10.80 91 12.2 9.85 - 14.55 42 6.1 4.31 - 7.89 
Point prev. 2 113 7.9 6.50 - 9.30 80 10.8 8.57 - 13.03 33 4.8 3.20 - 6.40 
12-month Prevalence  42 2.9 2.03 - 3.77 33 4.5  3.01 - 5.99 9 1.3 .45 - 2.15 
12-month Incidence 69 4.8 3.69 - 5.92 45 6.1 4.38 -7.82 24 3.5 2.13 - 4.87 
Notes. CI = 95 % Confidence interval, Point prev.1 and 2 at assessment points 1 and 2. 
Point prevalence (SMFQ ≥ 11) at first and second assessment point, 12-month prevalence (SMFQ ≥ 11) at assessment point 1 and 2), 
12-month incidence rate (new cases with SMFQ ≥ 11 from assessment point 1 to assessment point 2) by gender 





aimed at assessing depression and depressive 
symptoms among children and young adolescents 
(44). In contrast, Saluja and colleagues examined the 
presence of depressive symptoms during the past 12 
months employing two items to assess levels of 
depression.  
Based on previous research, we expected an 
increase in point prevalence from the first assessment 
point to the second assessment point. However, and 
contrary to our expectations, the results show a 
significant reduction in point prevalence between the 
assessment points. We expected an increase in the 
point prevalence because the population had become 
one year older at assessment point II, and previous 
research has strongly suggested an escalation in 
depressive symptoms when pupils, and specifically 
girls, go from childhood to adolescence (3, 22, 48, 61-
63). Puberty is a transitional phase that involves 
development in many aspects: brains mature, bodies 
change, independence in identity evolves, the 
development of their social environment expands. 
Moreover, increased awareness of appearance and 
comparison to others in e.g., social media increases, 
as well as interaction with the available social context 
they are part of (64-66). Another potential 
explanation for this may be a re-test effect. Arrindell 
(67) has shown that when samples are assessed on 
two occasions, using the same self-report inventory, 
a mean change in scores towards less 
psychopathology is often observed. The re-test effect 
has been demonstrated in such widely-employed 
state measures as the Beck Depression and Anxiety 
Inventory, the Depression Adjective Check Lists, the 
Profile of Mood States and the Symptom Checklist-
90 (67), but not for the SMFQ yet. Despite a possible 
re-test effect, the benefits of employing the same 
instrument in a longitudinal study is preferable (68).  
A second explanation may be that the level of 
depressive symptoms typically varies over time (69), 
so the reduction may also be part of natural 




Our study shows a 12-month prevalence of 2.9% for 
the entire sample, and 4.5 % and 1.3 % rate for girls 
and boys, respectively. Our findings are in 
accordance with a reported 12-month prevalence of 
2.7% assessed through clinical interviews using a 
sample of children and young adolescents between 8 
to15 years of age. Moreover, Haarasilta et al. reported 
a 12-month prevalence of DSM-III-R major 
depressive episode of 6% for girls and 4.4% for boys 
among 15 to19-year-olds. Although the results from 
this study indicate an overall smaller 12-month 
prevalence compared to Haarasilta et al. (71), who 
assessed an older sample, the results are noteworthy. 
The results show a 3 to 1, 12-month preponderance 
rate among girls compared to boys, whereas the point 
prevalence results show a 2-1 preponderance 
between girls and boys. A reasonable interpretation 
of this finding is that depressive symptoms among 
girls are more prevalent and fluctuate less compared 
to boys. Thus, the results demonstrate the 




The present study found a 12-month total incidence 
rate at 4.8%, more specifically 6.1% among girls and 
3.5% among boys. These results are somewhat 
smaller compared to what (27) reported. Assessing a 
sample of 1508 high school students (in 9th to 12th 
grade), they documented a 12-month incidence of 
10.4% and 4.8% for girls and boys, respectively. 
Further, in assessing 4,175 youths aged 11–17 (72), 
they reported a 12 month incidence of 1.5 % DSM‐
IV mood disorder. Discrepancies in the incidence 
rate may be due to differences in the age range of the 
samples used. Our sample consisted of pupils in 6th 
to 10th grade compared to Lewisohn’s sample, which 
was comprised of high school students in 9th to 12th 
grade.  
Our study shows that a relatively high number of 
children aged 11-14 experience significant depressive 
symptoms, which is in contrast to previous research 
reporting that the proportion of children and 
adolescents who struggle with a high depressive 
symptom load remains relatively low until young 
adolescence and then increases until the age of 17-18 
(33, 73, 74). Previous studies have indicated that 
depression and depressive symptoms have both a 
genetic anchoring and are partly influenced by the 
environment (75, 76). Environmental risk-factors 
like experiences of stress (77) and debut with alcohol 
become an increased focus on appearance among 
adolescents at 15 years of age (78). Moreover, with 
increasing age, school is perceived as more 
achievement oriented (79), and the level of 
interpersonal stressors are perceived as more 
prominent (35, 80) and are thus associated with 
depression (81).  
Most children and young people go through 
adolescence without insurmountable difficulties, but 
many also experience mental health problems. How 
children and young people experience adolescence is 
different; for most children and young people 
adolescence provides experiences and strains that 
lead to healthy development, while for others the 
same strains can lead to perceived stress and mental 
illness (82). 
The results from this study cannot provide 
evidence that older children and young adolescents 
experience overall more chronic stress compared to 





same-aged youth who grew up decades earlier. 
Nevertheless, the results from this study clearly 
demonstrate that older children and young 
adolescents report substantial depressive symptoms 
at an early age. Moreover, the results also 
demonstrate that many young girls suffer significant 
depressive symptoms. In that regard, Rudolph (80) 
has shown that an increase in perceived stress related 
to interpersonal stressors, specifically in adolescent 
girls, was found to be associated with a greater extent 
of depression in girls compared to boys (83, 84).  
Another interesting, and to a certain extent 
surprising, finding is the relatively large discrepancies 
in point prevalence, nearly 10% compared to a 12-
month prevalence of almost 3%. This may indicate 
that the level of depressive symptoms fluctuate in 
adolescents, as previously reported (37, 85). The 
gender difference in point prevalence was found to 
be 2:1, with about twice as many girls as boys 
reporting high levels of depressive symptoms. 
Further, three times as many girls as boys report 
persistent depressive symptoms. This indicates that 
depressive symptoms tend to persist to a greater 
extent in girls compared to boys. In our study, about 
1 in 3 adolescents with depressive symptoms have 
symptoms for one year or longer. Birmaher et al. (86) 
recorded that 1 out of 5 adolescents with depression 
show depressive symptoms for two years or longer. 
Discrepancies in persistent depressive symptoms 
between genders are likely to have many causes, both 
biological and social, and factors such as rumination. 
Rumination is most prevalent in women and an 
important factor in predicting variance in depressive 
symptoms over time (87, 88). Thus, further research 
has to explore if girls ruminate more extensively than 
boys even at a young age.  
Reporting bias can also be an explanation for the 
gender difference in depression. Boys and girls are 
socialised differently, which can affect the incidence 
of depression. Girls are socialised to express more 
sadness and to be more comfortable and familiar 
with talking about sadness and negative emotions, 
while boys are socialised to inhibit sadness. By boys 
hiding that they are sad and not telling about it, it can 
contribute to the gender difference in depression 
(89). In general, men are less likely to seek help for 
mental health problems, which may be due to 
expectations related to masculinity, gender roles and 
norms (90). 
Further studies should also explore the extent of 
the difference in depressive symptoms, comorbidity 
and functionality between those who report point 
prevalence and those who report 12-month 
prevalence. More specifically, future studies ought to 
examine the extent to which these two groups differ 
in other areas vital to healthy adaptation into 
adulthood, for instance, areas like quality of life, 
resilience, interpersonal relationships, anxiety and 
self-efficacy. It is also important to examine the 
extent to which these two groups differ in 
prognosing persistence, relapse and deterioration. 
Such information would be crucial to depression 
prevention and intervention research, and 
scientifically very interesting.  
Results from this study demonstrate that many 
older children and young adolescents experience 
depressive symptoms at a level that is alarming. 
Moreover, the finding that 3% of the population 
show a one-year consistency of substantial 
depressive symptoms highlights the need for more 
intervention tailored specifically for the middle-
school level and especially aimed at children and 
adolescents who experience persistent depressive 
symptoms. 
 
Methodological strengths and limitations 
This study has several strengths and some 
limitations. The study presents results from a 
longitudinal population-based survey among older 
children and young adolescents. Moreover, a 
recognised self-report instrument has been used. 
However, in order to verify a clinical depression 
diagnosis, diagnostic interviews are needed, which is 
also the case in assessing comorbid disorders.  
In this study we use data from pupils who 
answered the questionnaire at both measurement 
points, with a drop out-rate of 17.7 % from 
assessment point 1.  
 
Conclusion 
The aim of this study is to assess point prevalence, 
12-month prevalence and 12-month incidence 
regarding depressive symptoms in a population-
based sample of older children and young 
adolescents in 6th through 10th grade. To our 
knowledge, this is the first study reporting the 
prevalence of depressive symptoms at point-
prevalence, 12-month prevalence and 12-month 
incidence by assessing the same sample of older 
children and young adolescents aged 11-14 twice 
during a one-year period. Overall, the results 
demonstrate high rates of depressive symptoms at an 
early age and substantial gender differences, where 
girls report significantly higher prevalence compared 
to boys.  
The transition into adulthood is a critical period in 
life, with important implications for subsequent 
achievements and behaviour, and the emergence of 
depressive symptoms in young adulthood may have 
even more serious and long-lasting consequences 
than at other stages of life. Results from this study 
suggest that depressive symptoms are highly 
prevalent, and the study highlights the need for more 
intervention tailored to gender at the middle-school 





level especially aimed at older children and young 
adolescents who experience persistent depressive 
symptoms. Depressive symptoms are likely to coexist 
with other adolescent problem behaviours, such as 
bullying and substance use (91). Teachers or 
practitioners, who work with youths who have such 
symptoms/behaviours, should be aware of such 
depression; successful treatment of depression could 
lead to many other positive health and behavioural 
outcomes for these youths. Increased awareness of 
depression among this age group is the first step 
toward implementing effective intervention. 
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